2015”N


2014”N

1. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, and@Nakamura K.
Anticancer Res, 34i1j, 141-6 i2014j

2. Comparative Proteomics of Sera From HCC Patients With Different Origins.

Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR,Ghaderi A, Nakamura K, and Erfani N.

Hepat Mon, 14i1j, e13103 i2014j 

3. Proteomic analysis indicates that overexpression and nuclear translocation of lactoylglutathione lyase iGLO1jis associated with tumor progression in murine fibrosarcoma.

Wang Y, Kuramitsu Y,Tokuda K, Okada F, Baron B, Akada J, Kitagawa T, and Nakamura K.

Electrophoresis, 35i15j, 2195-202 i2014j

4. Fascin regulates chronic inflammation-related human colon carcinogenesis by

inhibiting cell anoikis.

Kanda Y, Kawaguchi T, Kuramitsu Y, Kitagawa T, Kobayashi T, Takahashi N,

Tazawa H, Habelhah H, Hamada J, Kobayashi M, Hirahata M, Onuma K, Osaki M, Nakamura K, Kitagawa T, Hosokawa M, and Okada F.

Proteomics, 14i9j, 1031-41 i2014j

5. Proteomic Characterization of Helicobacter pylori CagA Antigen Recognized by

 Child Serum Antibodies and Its Epitope Mapping by Peptide Array.

Akada J, Okuda M, Hiramoto N, Kitagawa T, Zhang X, Kamei S, Ito A, Nakamura M, Uchida T, Hiwatani T, Fukuda Y, Nakazawa T, Kuramitsu Y, and Nakamura K.
PLoS One, 9i8j, e104611 i2014j

6. Active hexose-correlated compound down-regulates Sex-determining region Y-box 2 ofpancreatic cancer cells.
Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S,

Kaino S, Maehara S, Maehara Y, Sakaida I, and Nakamura K.

Anticancer Research, 34i9j, 4807-4811 i2014j

7. Gemcitabine induces poly iADP-ribosej polymerase-1 iPARP-1j degradation through autophagy in pancreatic cancer.

Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, Maehara S, Maehara Y, and Nakamura K.

PLoS One, 9i10j, e109076 i2014)


2013”N“x‚܂ł̋ƐÑ

@‘O‹³Žö@’†‘º˜asæ¶Ý”C’†‚̋ƐÑ
@@@Ë@@(PDFƒtƒ@ƒCƒ‹j˜_•¶ˆê——
@@@Ë@@iPDFƒtƒ@ƒCƒ‹j’˜‘ˆê——